Choo Chee Kong's Form 4 filing
CytoMed Therapeutics Ltd (GDTC) · filed Jun 15, 2026
- Accession no.
- 0001493152-26-028589
- Filed
- Jun 15, 2026
- Trade date
- May 13, 2026
- Filing delay
- 33 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $128.8K. It was filed 33 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Choo Chee KongCIK 0001970632 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | Ordinary Shares, no par value per share | PPurchaseAcquired | +112,000 | $1.15 | +$128,800 | 430,324 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.